-transparent.png){kind=logo}
Serum levels of interferon gamma, interleukin-6 and neopterin were determined in 15 patients with different forms of Epstein-Barr virus-associated diseases: acute self-limiting infectious mononucleosis, chronic active infectious mononucleosis and X-linked lymphoproliferative syndrome. In patients with acute type of infection, neopterin, interferon gamma and interleukin-6 were elevated in nearly all patients. In contrast, the situation was less clear-cut in the other EBV-associated diseases; particularly interleukin-6 was undetectable in most cases. The results suggest that concomitant measurement of these diverse immune activation markers may provide interesting insights into the interactions between the virus and the host, and may also lead to therapeutic consequences.
V Schuster, and
M Herold, and
H Wachter, and
G Reibnegger
July 1999,
The American journal of pathology,
V Schuster, and
M Herold, and
H Wachter, and
G Reibnegger
September 1994,
Transplantation science,
V Schuster, and
M Herold, and
H Wachter, and
G Reibnegger
November 1977,
Pediatria polska,
V Schuster, and
M Herold, and
H Wachter, and
G Reibnegger
February 2001,
Clinical otolaryngology and allied sciences,
V Schuster, and
M Herold, and
H Wachter, and
G Reibnegger
March 1971,
Hippokrates,
V Schuster, and
M Herold, and
H Wachter, and
G Reibnegger
October 2004,
American family physician,
V Schuster, and
M Herold, and
H Wachter, and
G Reibnegger
March 1970,
Schweizerische medizinische Wochenschrift,
V Schuster, and
M Herold, and
H Wachter, and
G Reibnegger
November 2004,
Expert reviews in molecular medicine,
V Schuster, and
M Herold, and
H Wachter, and
G Reibnegger
February 1973,
The New England journal of medicine,
V Schuster, and
M Herold, and
H Wachter, and
G Reibnegger
August 2000,
Gastrointestinal endoscopy,
